Vitamin B2 Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Conditions:   Keratoconus;   Pellucid Marginal Corneal Degeneration;   Corneal Degeneration;   Corneal Ectasia Intervention:   Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution Sponsor:   Cornea Associates of Texas Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 26, 2019 Category: Research Source Type: clinical trials